SuRo Capital Corp. to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023
August 02, 2023 16:05 ET
|
SuRo Capital Corp.
NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”) (Nasdaq: SSSS) today announced that it will report its financial results for the quarter ended June 30, 2023 after the...
Arbutus to Report Second Quarter 2023 Financial Results and Provide Corporate Update
July 20, 2023 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., July 20, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop...